The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,750.00
Bid: 1,749.50
Ask: 1,750.00
Change: -6.00 (-0.34%)
Spread: 0.50 (0.029%)
Open: 1,743.50
High: 1,752.00
Low: 1,740.50
Prev. Close: 1,756.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FTSE 100 movers: Financials mixed as investor lock in profits

Fri, 22nd Jul 2011 14:18

The financial sector was mixed on Friday, despite rising strongly early on following yesterday's Eurozone deal to bailout Greece. Shares soared on Thursday after the region's leaders agreed a new aid package for Greece and an overhaul of the Eurozone sovereign rescue fund. While RBS bucked the trend amongst financials - with the part-nationalised bank gaining 2.36% to trade at 36.90p - other financial shares lost some of their earlier buoyancy as investors looked to lock in some profits following yesterday's gains. Lloyds and insurance peers Prudential, Old Mutual and Legal & General were prominent among the fallers.Aviva, however, rose higher after takeover rumours regarding the insurance firm resurfaced, citing two European peers (Allianz and Zurich Financial) to be potential suitors. Engineering peers IMI and Weir were among the top performers, gaining 3.48% and 1.93%, respectively.Silver mining giant Fresnillo, too, was a high riser tracking silver prices upwards. Silver futures were 2.52% up at $39.93 at 14:12 on Friday afternoon in London (09:31 in New York).Drugs giants AstraZeneca and GlaxoSmithKline fell into the red after UBS cut its rating on the European pharmaceutical sector from 'small overweight' to 'neutral', saying the defensive sector that benefited from the economic soft patch and the sovereign debt crisis will be hit by the turnaround in these lead indicators. Vodafone was firmer after reporting that revenue from its core business grew by 1.5% in the second quarter of 2011.Outsourcing giant Capita was in demand after the acquisition of the pensions administration and software business of NorthgateArinso for £27.5m.BCFTSE 100 - RisersIMI (IMI) 1,099.00p +3.48%Fresnillo (FRES) 1,687.00p +2.62%Royal Bank of Scotland Group (RBS) 36.90p +2.36%Capita Group (CPI) 700.00p +2.04%Weir Group (WEIR) 2,163.00p +1.93%Marks & Spencer Group (MKS) 360.50p +1.92%Vodafone Group (VOD) 164.25p +1.83%Vedanta Resources (VED) 1,881.00p +1.79%International Consolidated Airlines Group SA (IAG) 242.00p +1.77%WPP (WPP) 734.50p +1.66%FTSE 100 - FallersLloyds Banking Group (LLOY) 46.70p -1.82%Essar Energy (ESSR) 379.00p -1.30%Prudential (PRU) 689.50p -1.29%Old Mutual (OML) 130.00p -1.07%Legal & General Group (LGEN) 116.00p -1.02%Admiral Group (ADM) 1,572.00p -1.01%AstraZeneca (AZN) 3,061.50p -0.99%Rexam (REX) 380.70p -0.91%Investec (INVP) 503.50p -0.89%Amec (AMEC) 1,116.00p -0.80%
More News
3 Oct 2023 11:59

LONDON MARKET MIDDAY: HSBC and StanChart help FTSE 100 outperform

(Alliance News) - London's FTSE 100 grew in confidence as Tuesday morning progressed, going into the afternoon in the green and outperforming European peers.

Read more
25 Sep 2023 09:13

LONDON BROKER RATINGS: Jefferies raises AstraZeneca to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
25 Sep 2023 08:37

TOP NEWS: GSK's Arexvy vaccine approved for adults over 60 in Japan

(Alliance News) - GSK PLC on Monday said the Japan Ministry of Health, Labour & Welfare has approved Arexvy for adults over 60.

Read more
25 Sep 2023 07:28

GSK's RSV vaccine gets approval in Japan

(Sharecast News) - GSK announced on Monday that its vaccine, Arexvy, has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for preventing respiratory syncytial virus (RSV) disease in adults aged 60 and over.

Read more
19 Sep 2023 09:30

GSK says new HIV PrEP medication authorised by European Commission

(Alliance News) - GSK PLC on Tuesday said the European Commission has authorised ViiV Healthcare's "superior" drug Apretude to reduce the risk of sexually acquired HIV-1 infection.

Read more
18 Sep 2023 09:40

LONDON BROKER RATINGS: Jefferies likes Energean; JPMorgan raises IDS

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
18 Sep 2023 07:57

LONDON BRIEFING: Phoenix Group hails "impressive" first-half

(Alliance News) - Stocks in London are called lower on Monday, as investors focus on the week's upcoming central bank decisions.

Read more
18 Sep 2023 07:18

US FDA approves GSK treatment for myelofibrosis

(Sharecast News) - GSK announced on Monday that the US Food and Drug Administration (FDA) has granted approval for 'Ojjaara', or momelotinib, as a treatment for adults suffering from intermediate or high-risk myelofibrosis with anaemia, including cases of primary myelofibrosis or secondary myelofibrosis.

Read more
15 Sep 2023 21:52

GSK's Ojjaara approved in US for myelofibrosis patients with anaemia

(Alliance News) - GSK PLC on Friday said Ojjaara, also known as momelotinib, has been approved in the US and the "first and only" treatment indicated for myelofibrosis patients with anaemia.

Read more
11 Sep 2023 08:24

Japan accepts GSK's regulatory filing for momelotinib for blood cancer

(Alliance News) - GSK PLC on Monday reported regulatory progress for momelotinib, as Japan's Ministry of Health, Labour & Welfare accepted a review for the blood cancer-focused drug.

Read more
11 Sep 2023 07:54

LONDON BRIEFING: Restaurant Group sells Frankie & Benny's and Chiquito

(Alliance News) - Stocks in London are called higher on Monday, ahead of a busy week of interest rate decisions and economic data.

Read more
6 Sep 2023 09:32

LONDON BROKER RATINGS: Shore says 'buy' B&M; Peel Hunt likes Halfords

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
4 Sep 2023 06:00

More UK babies to need hospital treatment over delay of GSK's RSV jab

(Alliance News) - The nation's top children's doctor has warned a delay on a new vaccine to combat respiratory syncytial virus, or RSV, will mean more babies and infants will need hospital treatment this winter.

Read more
1 Sep 2023 09:11

GSK antibody accepted for Japan review, Goldman Sachs reduces stake

(Alliance News) - GSK PLC on Friday said a new drug application for its monoclonal antibody mepolizumab has been accepted for review by the Japanese government.

Read more
1 Sep 2023 07:49

LONDON BRIEFING: Stocks seen higher; UK house prices continue to fall

(Alliance News) - Stocks in London are set to open higher on Friday as markets looked ahead to a data-heavy day.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.